Vaccinia immune globulin (Emergent BioSolutions)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVaccinia immune globulin (Emergent BioSolutions)
Drug Alias NameC-VIG (Emergent BioSolutions)็‰›็—˜ๅ…็–ซ็ƒ่›‹็™ฝ - Emergent BioSolutions็‰›็—˜่‹—ๅ…็–ซ็ƒ่›‹็™ฝ - Emergent BioSolutionsVIG (Emergent BioSolutions)VIGIV (Emergent BioSolutions) +[6]ย 
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDrug-Related Side Effects and Adverse Reactions
Global Approved IndicationsDrug-Related Side Effects and Adverse Reactions
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2005/05/02
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCangene Corp
China Registration ClassN/A

Develop Information

Active CompaniesUs Department Of Health And Human Services
Inactive CompaniesN/A
Active IndicationsDrug-Related Side Effects and Adverse Reactions
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB07
Related LinksN/A